Support earlier, more connected cardiometabolic insight with Siemens Healthineers. Includes the first and only prognostic high-sensitivity troponin I assay available in the U.S. and the first and only blood test authorized for use as a prognostic marker in patients with advanced fibrosis due to MASH. Enable a more complete testing approach without added complexity.